Case Study: Staying Ahead in an Evolving Reimbursement and Market Access Policy Landscape

Case Study: Staying Ahead in an Evolving Reimbursement and Market Access Policy Landscape

Client Challenge

Our client, a pharmaceutical company with a diverse pipeline of assets, aims to stay informed of developments in the reimbursement and market access policy environment across multiple therapeutic areas. Having a thorough understanding of these developments is critical for the organisation to identify the strategic factors that may influence the success of future product launches in the UK.

Kintiga Approach

Kintiga delivers a fortnightly policy tracker report that provides concise updates on key developments in health technology assessment (HTA), market access and relevant therapy areas. It brings together information from government agencies, patient groups, professional bodies, think tanks and policymakers.

The report is designed as an infographic to enhance readability. It incorporates Kintiga insights drawn from our knowledge and extensive experience.

The policy tracker is shared across multiple client teams. This helps to ensure widespread access to information and facilitates insightful strategic decision-making.

Results

The policy tracker provides the following benefits to our client:

  • It ensures an up-to-date understanding of the evolving reimbursement, market access and therapy area landscape
  • It heightens awareness of risks, challenges, and opportunities in the environment
  • It informs strategic thinking and planning across various departments
  • It deepens knowledge of multiple therapy areas and their stakeholder
"Using the policy tracker service has been key in deepening our understanding of the evolving HTA and market access environment. It has enhanced our learning across various therapy areas including those we are not currently active in, whilst also providing valuable insights for our strategic planning."

Our expertise:

Related articles

Get in touch

Contact us to discover more about Kintiga and how we can help shape a future of impactful, patient-focused solutions across Europe.

Between Ambition & Reality: Why German Routine Practice Data Collection Often Stalls
Scroll to Top